Perrigo | PRGO - Текущие активы





Текущие активы Изменить Дата
AbbVie USD 33.67B 140M 2026-06
Abbott USD 25.51B 488M 2026-03
Bayer EUR 33.64B 1.66B 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Dr.Reddys Laboratories INR 297.32B 2.01B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
J&J USD 56.35B 3.42B 2026-09
Merck USD 36.68B 1.66B 2026-06
Nestle CHF 37.58B 5.61B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 45.01B 3.65B 2026-09
Phibro Animal Health USD 935.51M 41.44M 2026-06
Prestige Brands USD 496.81M 65.33M 2026-06
Reckitt Benckiser GBP 4.6B 287M 2024-12
Sanofi EUR 33.21B 1.68B 2026-09
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zoetis USD 6.36B 118M 2026-06